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ABSTRACT. This study aimed to evaluate the immunomodulatory and 
neuroprotective effects of allogeneic and cryopreserved mesenchymal 
stem cells (MSCs) on spinal cord injury. A total of 120 rats were 
distributed into the following groups: negative control (NC) - without 
injury, positive control (PC) - with injury without treatment, and group 
2I.R. Rosado et al.
Genetics and Molecular Research 16 (1): gmr16019555
treated with MSC (GMSC) - with injury and treated. Motor function 
was evaluated by the BBB test at 24, 48, and 72 h and at 8 and 21 
postoperative days. Spinal cords were evaluated by histopathology and 
immunohistochemistry to determine the expression of CD68, NeuN, 
and GFAP. IL-10, TNF-α, IL-1β, TGF-β, BDNF, GDNF, and VEGF 
expression was quantified by RT-PCR. The GMSC presented higher 
scores for motor function at 72 h and 8 and 21 days after injury, lower 
expression of CD68 at 8 days, and lower expression of GFAP at 21 
days compared to the PC. In addition, higher expression of NeuN and 
lower degeneration of the white matter occurred at 21 days. The GMSC 
also showed higher expression of IL-10 24 h after injury, GDNF at 
48 h and 8 days, and VEGF at 21 days. Moreover, lower expression 
of TNF-α was observed at 8 and 21 days and TGF-β at 24 h and 21 
days. There were no differences in the expression of IL-1β and BDNF 
between the GMSC and PC. Thus, cryopreserved MSCs promote 
immunomodulatory and neuroprotective effects in rats with spinal cord 
injury by increasing IL-10, GDNF, and VEGF expression and reducing 
TNF-α and TGF-β expression.
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INTRODUCTION
Approximately 2.5 million individuals worldwide have suffered from spinal cord 
injury (SCI). Frequently, this type of lesion results in severe and permanent neurological 
deficits, causing affected individuals to require constant medical care and nursing (Sekhon and 
Fehlings, 2001). The neurological deficits caused by spinal cord injury result from the direct 
disruption of neuronal pathways and from progressive secondary changes causing lesion 
expansion (Brewer et al., 1999; Dasari et al., 2007).
There are three phases in the response to SCI. The acute phase occurs immediately after 
injury and extends until the seventh day after the lesion. In this phase, the release of pro-inflammatory 
cytokines is initiated, microglia are activated, and neutrophils and monocytes migrate to the lesion. 
From the seventh to the fourteenth day after the lesion is initiated, a subacute phase occurs, which 
is characterized by the persistence of the inflammatory reaction and by increased production of 
free radicals. These secondary changes cause lipid peroxidation and induce apoptosis of neurons 
and oligodendrocytes. In the chronic phase, which extends from 2 weeks to several months after 
injury, glial scar formation and degeneration of axons and myelin occur (Nandoe Tewarie et al., 
2009). Therefore, an important characteristic of SCI pathogenesis is that the final lesion is much 
larger than the primary injury (Popovich et al., 1997). Thus, the rapid introduction of treatment 
is essential for stopping these secondary events and limiting tissue loss. Nevertheless, there are 
no effective therapies for this condition, although many studies have attempted to find effective 
therapeutic alternatives. Therapy with mesenchymal stem cells (MSCs) is considered a promising 
option, because these cells are multipotent and can easily be isolated from adult individuals and 
expanded in vitro (Osaka et al., 2010; Zhukareva et al., 2010; Nakajima et al., 2012; Dariolli et al., 
2013; Zhou et al., 2013; Kingham et al., 2014; Lin et al., 2014).
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The administration of MSCs during the acute or subacute phase of SCI shows better 
results than administration during the chronic phase (Dasari et al., 2007; Nandoe Tewarie et al., 
2009; Osaka et al., 2010; Zhukareva et al., 2010; Hawryluk et al., 2012; Nakajima et al., 2012). 
These results support the hypothesis that MSCs can act in secondary events favoring neuronal 
survival and regeneration (Nakamura et al., 2003; Yune et al., 2003; Mead et al., 2014).
The isolation, cultivation, and expansion of MSCs require 2-3 weeks, limiting their 
early administration. This may be overcome by using cryopreserved MSCs (Dariolli et al., 
2013; Davies et al., 2014).
SCI lesion models in rodents have proved to be useful in studies of pathogenesis and 
therapy (Popovich et al., 1997; Brewer et al., 1999; Nakamura et al., 2003; Yune et al., 2003; 
Dasari et al., 2007; Nandoe Tewarie et al., 2009).
Thus, the objective of the present study was to evaluate the immunomodulatory and 
neuroprotective effects of cryopreserved MSCs administered intravenously in rats subjected to SCI.
MATERIAL AND METHODS
The present study was developed in accordance with International Standards of 
Animal Welfare following approval by the Ethics Committee in Animal Experimentation 
at Universidade Federal de Minas Gerais (CEUA No. 41/2012). Animals were housed in 
individual cages and maintained at 23°C, 12-h light/dark cycle, fed with commercial chow 
and tap water ad libitum.
Isolation and cultivation of MSCs from adipose tissues of ten 4-week-old male 
GFP Lewis rats (LEW-Tg and GFP F455/Rrrc) weighing 200g were used for the isolation 
of MSCs. Retroperitoneal fat was harvested, and the MSCs were isolated as described by 
Carvalho et al. (2013).
Cell characterization
For their phenotype characterization, 5 x 106 MSCs were incubated with the following 
primary mouse anti-rat antibodies: CD45, CD54, CD73, CD90, CD11, MHCI, and MHCII 
(Abcam, Cambridge, UK) for 30 min at 4°C. The samples were then washed with PBS and 
incubated with secondary anti-mouse Alexa 488 antibody (Molecular Probes, Eugene, OR, 
USA) for 30 min at 4°C. Next, MSCs were washed and suspended in PBS. The quantification 
of the cells stained with each antibody was performed using a FACScan flow cytometer 
(BD Biosciences, Franklin Lakes, NJ, USA) with 30,000 events per sample and analyzed 
using the Cell Quest software (BD Biosciences). A sample of cells was incubated with only 
the secondary antibody to control non-specific reaction. Phenotypical characterization was 
performed before and after cell thawing.
MSCs were also evaluated for their differentiation potential before and after thawing. 
For osteogenic differentiation, MSCs were maintained in DMEM containing 10% fetal bovine 
serum (FBS), 0,1 µM  dexamethasone, 50 mg/mL ascorbic acid-2-phosphate, and 10.0 mM 
β-glycerophosphate (Sigma, St. Louis, MO, USA) for 21 days at 37°C and 5% CO2. On 
the 21st day, the cultures were stained as described by Von Kossa to assess the presence of 
mineralization nodules. For adipogenic differentiation, MSCs were maintained in DMEM 
containing 10% FBS, 1.0 µM f dexamethasone, 10.0 µL/mL insulin, 100 mM indomethacin, 
and 500 mM 3-isobutyl-1-methylxanthine (Sigma) for 21 days at 37°C and 5% CO2. On 
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the 21st day, the cells were subjected to Oil Red O staining and assessed for deposition of 
intracellular lipid vesicles. Chondrogenic differentiation was performed in 3-D spheroid 
culture, with 1 x 106 cells maintained in DMEM containing 10% FBS, 0.0125 g/mL bovine 
serum albumin, 100 µM sodium pyruvate, 6.25 mg/mL insulin, 6.25 mg/mL transferrin, 50 
µM ascorbic acid-2-phosphate, 100 nM dexamethasone, and 10.0 ng/mL transforming growth 
factor-beta 1 (TGF-b1), for 21 days at 37°C and 5% CO2. On the 21st day, the cells were fixed 
in 4% paraformaldehyde and embedded in paraffin. Histological sections were prepared from 
pellets and proteoglycans were stained with Alcian blue.
Cryopreservation of MSCs
MSCs from the fourth passage were cryopreserved. For this, MSCs were detached 
from the flasks by trypsin, centrifuged at 1500 rpm for 10 min at 23°C, and pellets were diluted 
in cell cryopreservation medium (50% v/v DMEM + 40% v/v FBS + 10% v/v DMSO). MSCs 
(1 x 106) were stored in 2-mL cryogenic vials containing 1.5 mL medium. The cryotubes were 
placed in Mr. Frosty Cryo Freezing Container® filled with isopropyl alcohol in the lower 
compartment. Subsequently the container was kept for 24 h in freezer -70/80°C to gradual 
cooling until freezing, and then removed from the container and stored in the freezer at 
-70/80°C for 2-3 months.
Cellular analyses
Forty-eight hours before transplantation, the MSCs were thawed in a water bath at 
37°C for 30 s. After thawing, MSCs were immediately washed in PBS, plated on DMEM, and 
maintained in an incubator at 37°C and 5% CO2 until transplantation. The viability of MSCs 
was evaluated before and after cryopreservation, using trypan blue staining and the MTT 
viability test.
Surgical procedure
To study SCI, 120 male Wistar rats weighing 300 g each were used. Animals were 
pre-medicated with morphine (5.0 mg/kg, sc), and anesthetic induction and maintenance with 
isoflurane was provided through a facial mask in a semi-open system. Antibiotic therapy of 
cephalothin (60 mg/kg, sc) was administered for antisepsis of the surgical field and prophylaxis. 
Laminectomy of the tenth thoracic vertebra (T10) was performed using a pneumatic drill. 
After visualization of the spinal cord covered by intact dura mater, compressive SCI was 
induced using a French Fogarty No. 2 catheter. The catheter was introduced into the epidural 
space and conducted cranially to the T8-T9 segment; the catheter balloon was filled with 30 
µL 0.9% saline solution, and pressure was maintained on the spinal cord for 5 min. During 
anesthetic recovery, the animals received oxygen therapy and were maintained at 37°C. 
During the postoperative period, the animals received morphine (5.0 mg/kg, sc) every 8 h for 
3 consecutive days.
Treatment
The therapeutic protocol consisted of injection with 1 x 106 MSCs in 0.5 mL 0.15 M 
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PBS, administered in a single dose intravenously in the coccygeal lateral vein 3 h after SCI. 
Controls received only 0.15 M PBS by the same route 3 h after SCI or laminectomy.
Experimental groups
The animals were distributed into three experimental groups: NC (negative control) 
subjected to laminectomy and treated with placebo (N = 20); PC (positive control) subjected 
to SCI and treated with placebo (N = 50); GMSC (group treated with mesenchymal stem cell) 
subjected to SCI and treated with MSCs (N = 50). Each group was evaluated at 24, 48, and 72 
h and at 8 and 21 days after the surgical procedure. Animals were allocated to experimental 
groups by randomization.
Histopathological analysis, immunohistochemistry, and reverse transcriptase-
polymerase chain reaction (RT-PCR)
After the evaluation periods, the animals were sacrificed with an overdose of 
intraperitoneal sodium thiopental, and blood was collected by cardiac puncture.
Histopathological and immunohistochemical evaluations were carried out 8 and 21 days 
after the surgical procedures. The vertebral columns were removed and fixed in 4% buffered 
paraformaldehyde for 24 h and subsequently transferred to 70% alcohol and stored until they 
were embedded in paraffin. Next, 4-mm segments centered at the epicenter of the lesion were 
removed, embedded in paraffin, and cut into serial sections, which were stained with hematoxylin 
and eosin for optical microscopy evaluation. For histopathological analysis, two slides were 
selected per animal, containing focally extensive necrosis area in the dorsal funiculus, one from 
the cranial region and the other from the caudal region to the epicenter of the lesion. In NC 
group animals, histological sections from the epicenter region were used. Immunohistochemical 
evaluation of animals subjected to injury focused on the first histological section of the caudal 
region to the epicenter containing the focally extensive necrosis area in the dorsal funiculus. The 
primary antibodies used were: 1:500 anti-eGFP (Abcam), 1:200 anti-CD68 (Abcam), 1:500 anti-
NeuN (Chemicon, Billerica, MA, USA), and 1:200 anti-GFAP (Abcam).
The spinal cord sections were deparaffinized and dehydrated using standardized 
protocols. Antigenic recovery was performed by heating the slides in 0.05% citric acid 
solution. Endogenous peroxidase was blocked in a solution of methanol and 3% H2O2 in a 
dark chamber, and non-specific epitopes in the protein (DAKO, Glostrup, Denmark) were 
blocked in a dark and humidified chamber. The histological sections were incubated overnight 
in the dark and humid chamber with the primary antibodies. Secondary antibody (DAKO) 
was added, and the sections were incubated under the same conditions for 45 min. Next, 
streptavidin-biotin peroxidase complex (DAKO) was added. The reactions were observed 
with 3-3'-diaminobenzidine peroxidase (DAKO), washed in water, and counterstained with 
Harris hematoxylin. Next, standardized dehydration and slides with cover glass and Canada 
balsam were prepared. The slides were photographed and analyzed using the ImageJ analysis 
software (NIH, Bethesda, MA, USA). For each image, the average integrated pixel density of 
the cells was subtracted from the background.
RT-PCR was performed for samples from 24, 48, and 72 h and 8 and 21 days after the 
surgical procedure. First, 1.5-cm segments of the spinal cord centered in the epicenter of the lesion 
were obtained, and the samples were placed in RNAase- and DNAase-free cryotubes containing 
6I.R. Rosado et al.
Genetics and Molecular Research 16 (1): gmr16019555
1.0 mL Trizol (Invitrogen, Carlsbad, CA, USA). The samples were frozen in liquid nitrogen 
(-196°C) and stored at -80°C. Total RNA was extracted, and RNA reverse transcription and RT-
PCR were performed as described by de Lavor et al. (2015). Primer sequences are shown in Table 
1. RT-PCR data were analyzed using the 7500 v.2.0.1 software from Applied Biosystems (Foster 
City, CA, USA) using the comparative cycle threshold method (Livak and Schmittgen, 2001). 
Gene expression was calculated using the 2-∆∆Ct method, where the results obtained for each group 
were compared quantitatively after normalization based on the expression of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) from Rattus norvegicus. The expression levels obtained in 
the NC were used as the standard for calculating the relative expression of each transcript.
Table 1. Genes with the primer sequences for real-time RT-PCR.
Gene Accession No. Oligonucleotide sequence (5'-3') Product size 
IL-10 NM_012854.2 F: CCCAGAAATCAAGGAGCATTT 64 
R: CAGCTGTATCCAGAGGGTCTTCA 
TNF- NM_012675.3 F: AACACATCTCCCTCCGGAAA 64 
R: CCAGTTCCACATCTCGGATCA 
IL-1 M98820 F: TGACAGACCCCAAAAGATTAAGG 61 
R: CTCATCTGGACAGCCCAAGTC 
TGF- AY550025.1 F: GAAACGGAAGCGCATCGA 59 
R: TGGCGAGCCTTAGTTTGGA 
BDNF NM_012513.3 F: CACAATGTTCCACCAGGTG 89 
R: TGGGCGCAGCCTTCAT 
GDNF EU068472 F: GAGAGAGGAACCGGCAAGCT 59 
R: GCGACCTTTCCCTCTGGAAT 
VEGF NC_013899.1 F: AAATCCTGGAGCGTTCACTGTG 106 
R: AACGCGAGTCTGTGTTTTTGC 
GAPDH NC_005103.3 F: TGCACCACCAACTGCTTA 97 
R: GGATGCAGGGATGATGTTC 
 
Evaluation of motor function
Motor function was evaluated in an open field using the Basso, Beattie, and Bresnahan 
(BBB) test (Basso et al, 1996). The animals were filmed for 5 min, and the videos were evaluated 
by two observers who were unaware of the groups and treatments. Evaluations were performed 
24 h before the surgical procedure, 24 h after, and weekly until 21 days after surgery.
Statistical analysis
The experiment was conducted in a completely randomized 3 x 5-factorial design (three 
experimental groups and five evaluation periods). Analysis of variance and calculation of the 
means, medians, and standard deviations was performed for each variable. The parametric data 
that did not present a normal distribution and homoscedasticity were submitted to logarithmic 
transformation [x = log(y + 1)]. The means of gene expression and integrated density of pixels 
were compared by the non-paired t-test, and the scores of motor evaluation were compared by 
the non-parametric Mann-Whitney test. The level of significance was set to 5%.
RESULTS
Isolation, cultivation, and characterization of MSCs
The MSCs presented an elongated and fusiform morphology in culture. Phenotypic 
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characterization of MSCs by flow cytometry showed that the cells were similar before freezing 
and after thawing. High expression of the markers CD54 (89.71 ± 9.55%), CD73 (90.07 ± 
5.25%), CD90 (91.28 ± 6.5%), and MHCI (92.69 ± 6.35%) was observed. The expression of 
hematopoietic cell markers was low: CD45 (4.93 ± 1.4%), CD34 (4.83 ± 0.62%), CD11b/c 
(5.37 ± 1.64%), and MHCII (9.1 ± 7.1%) (Figure 1).
MSCs grown in osteogenic medium acquired an osteoblast phenotype and presented 
mineralization of the extracellular matrix as demonstrated by Von Kossa staining. After 
cultivation in chondrogenic differentiation medium, the chondrocytes derived from MSCs 
produced and deposited proteoglycans in the extracellular matrix as observed by Alcian 
blue staining. Finally, after adipogenic induction, adipocytes derived from MSCs presented 
birefringent lipid vesicles within their cytoplasm, as observed by Oil Red O staining.
Figure 1. A. Histograms of the expression of CD11, CD34, CD45, CD54, CD73, CD90, MHCI, and MHCII by flow 
cytometry in cultures of MSCs of rat adipose tissue. The white graph represents the population of cells evaluated for 
a specific marker (offset to the right indicates the existence of staining). B. Percentage of cells expressing the markers 
CD11, CD34, CD45, CD54, CD73, CD90, MHCI, and MHCII before freezing and 60 and 90 days after freezing.
Assessment of cell viability by trypan blue and conversion of MTT into formazan 
crystals
The percentage of viable cells was 97.03 ± 0.25% before freezing. When frozen for 
60 days, the cellular viability was 84.87 ± 0.81%, and after 90 days, this value was 81.83 
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± 3.72%. Thus, cell viability decreased after cryopreservation and thawing. There was no 
difference in cellular viability between 60 and 90 days of freezing (Figure 2A).
The conversion of MTT into formazan crystals was higher in MSCs after 90 days of 
freezing compared to that before freezing (Figure 2B).
Figure 2. A. Means and standard deviations of the percentage of viable cells in MSCs cultured from rat adipose 
tissue before freezing and 60 and 90 days after freezing. B. Means and standard deviations of the conversion of 
MTT in MSC cultures before freezing and 90 days after freezing (*P < 0.05).
Histopathological analysis
The spinal cords of rats in the negative control group showed normal architecture 
(Figure 3A, B). However, the spinal cords of animals with injury showed uniform lesions. In 
the epicenter region, the spinal cords showed intense diffuse malacia affecting all of the white 
and gray matter (Figure 3C).
After 8 days, the histological sections from the cranial and caudal regions of the GMSC 
and PC presented focally extensive malacia areas, affecting the dorsal funiculus (Figure 3D-
G), and degenerated neurons were observed in the gray matter (Figure 3H). Discreet axonal 
degeneration and myelin tumefaction occurred in the white matter (Figure 3I).
At 21 days, cranial and caudal segments of the cords of GMSC and PC animals 
presented areas of focally extensive malacia affecting the dorsal funiculus (Figure 4A-D). 
Evaluation of gray matter revealed some degenerated neurons. Discreet to moderate axonal 
degeneration and tumefaction of myelin occurred in the white matter. This finding was greater 
in the PC group than in the GMSC group (Figure 4E).
Immunohistochemistry analysis
Immunohistochemical staining with anti-eGFP antibody allowed for visualization of the 
MSCs in the spinal cord 8 and 21 days after administration. MSCs were identified in the gray 
matter in the caudal segments and in the malacia region at the lesion epicenter (Figure 5A, B).
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Figure 3. Photomicrographs of hematoxylin and eosin-stained spinal cords of rats 8 days after laminectomy 
and spinal cord injury. A. and B. Spinal cord of animal subjected only to laminectomy presenting normal tissue 
architecture (A) and intact neurons (arrows in B). C. Epicenter of the spinal medulla of animal subjected to injury 
presenting malacia affecting all white and gray matter. Cranial (D) and caudal regions (E) of the spinal cord in animal 
subjected to injury and treated with MSCs; note focally extensive areas of malacia affecting the dorsal funiculus 
and discreet axonal degeneration and tumefaction of myelin affecting the dorsal and lateral funiculi. Cranial (F) and 
caudal (G) regions of the spinal cords of animal subjected to injury without treatment; note focally extensive areas 
of malacia affecting the dorsal funiculus and discreet axonal degeneration and tumefaction of myelin affecting the 
dorsal and lateral funiculi. H. Degenerated neurons (arrows) in animals subjected to injury without treatment. I. 
Degeneration of white matter with tumefaction of axons and myelin sheath (arrows) in animal subjected to injury 
without treatment (A, C, D, E, F, G: bar = 285 mm, magnification 50X; B, H, I: bar = 35 mm, magnification 400X).
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Figure 4. Photomicrographs of spinal cords of rats 21 days after laminectomy and spinal cord injury, HE staining: 
cranial (A) and caudal regions (B) of spinal cord of animal subjected to injury and treated with MSCs. Cranial (C) 
and caudal regions (D) of spinal cord of rats subjected to injury without treatment. Axonal and mild to moderate, 
diffuse myelin degeneration was less intense in the group treated with MSCs. E. White matter of the spinal cord of 
animal subjected to injury without treatment, displaying degeneration of axons and myelin sheath (arrows). (A, B, 
C, D: bar = 285 mm, magnification 50X; E: bar = 35 mm, magnification 400X).
Figure 5. Photomicrographs of spinal cords of rats subjected to injury and treated with MSCs. Evaluation by anti-
eGFP immunohistochemistry. MSCs staining in gray matter (A) and in the epicenter region (B) (bar = 23 mm, 
magnification 400X).
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There was no difference in the expression of CD68 in the dorsal funiculus between 
the PC (12.91 x 106 ± 8.31 x 106) and GMSC (16.91 x 106 ± 10.67 x 106) (Figure 6A). The 
expression of CD68 was significantly lower in the NC (0.04 x 106 ± 0.01 x 106) compared to 
the GMSC and PC (Figure 6B, C, D). A difference was observed between groups regarding 
the morphological characteristics of stained cells. In the GMSC, the cells were larger and with 
foamy cytoplasm, while in the PC, they presented smaller and denser cytoplasm (Figure 6E, F).
Figure 6. A. Means and standard deviations of the expression of CD68 in the region of the dorsal funiculus of cords 
in the negative control group (NC), group treated with mesenchymal stem cells (GMSC), and positive control group 
(PC) 8 days after laminectomy or injury (*P < 0.05). Photomicrographs of spinal cords evaluated by anti-CD68 
immunohistochemistry 8 days after surgery (C-F). Discreet staining in the NC (B) and intense staining in the region 
of malacia in the dorsal funiculus of cords from the GMSC (C) and PC (D). Dorsal funiculus of spinal cord of 
GMSC (E) and PC (F). Stained cells in the GMSC (E) showed larger volumes and less dense cytoplasm compared 
to the PC (F) (B, C, D: bar = 285 mm, magnification 50X; E, F: bar = 35 mm, magnification 400X).
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At 8 days, the expression of CD68 in the white matter was significantly lower in the 
NC (0.05 x 106 ± 0.02 x 106) and GMSC (0.56 x 106 ± 0.39 x 106) compared to in the PC (2.92 
x 106 ± 2.71 x 106) (Figure 7A, D, F, H).
At 8 days, the expression of CD68 in the gray matter was significantly lower in NC 
(0.04 x 106 ± 0.01 x 106) and GMSC (1.84 x 106 ± 1.58 x 106) compared to the PC (5.54 x 106 
± 4.24 x 106) (Figure 7B, C, E, G).
Figure 7. Means and standard deviations of CD68 expression in white (A) and gray matter (B) of spinal cords 
of rats in the negative control group (NC), group treated with mesenchymal stem cells (GMSC), and the positive 
control (PC) group evaluated 8 days after laminectomy or injury (*P < 0.05). Photomicrographs of spinal cords 
evaluated by anti-CD68 immunohistochemistry 8 days after surgery (C, D, E, F, G, H). Observe the insignificant 
staining in the white (C) and gray matter (D) of NC animals, discreet in the white (E) and gray matter (F) of the 
GMSC, and intense staining in the white matter (G) and gray matter (H) of animals in the PC (bar = 35 mm, 
magnification 400X).
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At 21 days after injury, there was no difference in the expression of CD68 in the white 
and gray matter in GMSC (3.73 x 106 ± 3.61 x 106; 2.15 x 106 ± 1.91 x 106) and PC (2.66 x 106 
± 1.66 x 106; 1.64 x 106 ± 1.45 x 106). Staining in these groups (GMSC and PC) was higher 
than in the NC (0.74 x106 ± 0.58 x 106; 0.04 x 106 ± 0.01 x 106) (Figure 8A, B, C).
Figure 8. Means and standard deviations of CD68 expression in the dorsal funiculus (A), in white (B) and gray 
matter (C) of spinal cords of rats in the negative control (NC), treated with mesenchymal stem cells (MSC), and the 
positive control group (PC) 21 days after laminectomy or injury (*P < 0.05).
At 8 days after injury following staining with the anti-NeuN antibody, the spinal cords 
of animals in the NC and PC presented non-uniform staining of the cytoplasm and neuron 
nuclei; unstained neurons and other neurons showed different staining intensities (Figure 9C, 
E). In the GMSC, neurons presented only cytoplasmic staining (Figure 9D). NeuN expression 
was significantly higher in the NC (1.67 x 107 ± 0.91 x 107) than in the PC (0.98 x 107 ± 0.25 
x 107) followed by the GMSC (0.28 x 107 ± 0.20 x 107), which displayed less intense staining 
(Figure 9A).
In the assessments 21 days after injury, GMSC showed nuclear and cytoplasmic 
staining, similarly to in NC and PC (Figure 9F, G, H). NeuN expression was significantly 
higher in the NC (1.67 x 107 ± 0.91 x 107) and GMSC (1.69 x 107 ± 0.83 x 107) than in the PC 
(0.80 x 107 ± 0.38 x 107) (Figure 9B).
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Staining of astrocyte extensions with the GFAP antibody in the spinal cords from 
animals in the NC, GMSC, and PC, evaluated at 8 and 21 days, was cytoplasmic. This staining 
was not uniform, as the distribution of the stained extensions varied between white and gray 
matter (Figure 10A, B, C, D).
In the evaluation performed 8 days after injury, comparison of the means obtained 
only in the dorsal funiculus revealed higher expression in the PC (1.34 x 107 ± 0.67 x 107) than 
in the NC (0.52 x 107 ± 0.25 x 107) and GMSC (0.14 x 107 ± 0.06 x 107). The GMSC displayed 
the lowest staining (Figure 10A, E, F, G). There was no difference in expression in the white 
and gray matter at 8 days between the NC (1.80 x 107 ± 0.64 x 107; 1.01 x 107 ± 0.75 x 107), 
GMSC (1.79 x 107 ± 0.33 x 107; 1.90 x 107 ± 0.34 x 107), and PC (1.76 x 107 ± 0.40 x 107; 2.02 
x 107 ± 0.57 x 107) (Figure 11A, B).
Figure 9. Means and standard deviations of NeuN expression in the spinal cords of rats in the negative control 
(NC) group treated with mesenchymal stem cells (GMSC), and the positive control group (PC) at 8 (A) and 21 
(B) days after laminectomy or injury (*P < 0.05). Photomicrographs of spinal cords evaluated by anti-NeuN 
immunohistochemistry (C, D, E, F, G, H). Higher staining was observed in the NC (C), moderate staining in PC 
(E) and lower staining in the GMSC (D) at 8 days. At 21 days, higher staining was observed in NC (F) and GMSC 
(G) compared to the PC (H) (C, D, E, F, G, H: bar = 35 mm, magnification 400X).
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Figure 10. A. Means and standard deviations of GFAP expression in the region of the dorsal funiculus of spinal 
cords of rats in the negative control (NC), treated with mesenchymal stem cells (GMSC), and positive control group 
(PC) 8 days after laminectomy or injury (*P < 0.05). Photomicrographs of spinal cords evaluated by anti-GFAP 
immunohistochemistry (B, C, D, E, F, G). Staining of the extensions of astrocytes observed in white and gray 
matter of the spinal cords of animals in the NC (B), GMSC (C), and PC (D). In the regions of the dorsal funiculus, 
less intense staining was observed in the GMSC (F), intermediate in the NC (E), and intense in PC (G) (B, C, D: 
bar = 285 mm, magnification 50X; E, F, G: bar = 35 mm, magnification 400X).
Figure 11. Means and standard deviations of GFAP expression in white (A) and gray matter (B) of spinal cords of 
rats in the negative control (NC), treated with mesenchymal stem cells (GMSC), and positive control group (PC) 
evaluated 8 days after laminectomy or injury (*P < 0.05).
16I.R. Rosado et al.
Genetics and Molecular Research 16 (1): gmr16019555
At 21 days, there was no difference in GFAP expression in the white matter between 
the NC (1.80 x 107 ± 0.64 x 107), GMSC (1.61 x 107 ± 0.29 x 107), and PC (1.59 x 107 ± 0.34 
x 107) (Figure 12A). Additionally, in the gray matter GFAP expression was higher in the PC 
(1.73 x 107 ± 0.49 x 107) than in the GMSC (1.06 x 107 ± 0.52 x 107) and NC (1.01 x 107 ± 0.75 
x 107) (Figure 12B, D, E, F). When only the dorsal funiculus was evaluated, expression was 
higher in the PC (1.37 x 107 ± 0.91 x 107) and GMSC (1.43 x 107 ± 0.60 x 107) than in the NC 
(0.52 x 107 ± 0.25 x 107) (Figure 12C).
Figure 12. Means and standard deviations of GFAP expression in the dorsal funiculus (A) and white (B) and gray 
matter (C) of the spinal cords of rats in the negative control (NC), treated with mesenchymal stem cells (GMSC), 
and positive control group (PC) at 21 days after laminectomy or injury (*P < 0.05). Photomicrographs of spinal 
cords evaluated by anti-GFAP immunohistochemistry (D, E, F). Less intense staining was observed in the gray 
matter in the NC (D) and GMSC (E) and higher in the PC (F) (A, B, C: bar = 35 mm).
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RT-PCR analysis
Relative expression of IL-10 was higher in the GMSC (7.57 ± 1.88) than in the PC 
(2.54 ± 0.79) at 24 h post-injury. No significant differences were observed between the GMSC 
and PC at 48 h (1.56 ± 0.67; 1.48 ± 1.09), 72 h (1.13 ± 0.43; 2.42 ± 1.45), 8 days (0.18 ± 0.17; 
0.26 ± 0.28), and 21 days (0.04 ± 0.03; 0.08 ± 0.02) (Figure 13A).
Relative expression of TNF-α was lower in the GMSC than in the PC at 8 (0.51 ± 
0.31; 1.72 ± 1.38) and 21 days (1.05 ± 0.31; 2.94 ± 1.32) (P < 0.05). There was no difference in 
the relative expression of TNF-α among groups at 24 h (4.03 ± 3.83; 6.25 ± 4.54), 48 h (4.17 
± 1.04; 4.25 ± 0.82), and 72 h (2.56 ± 2.20; 4.94 ± 2.68) after SCI (Figure 13B).
There was no difference in the relative expression of IL-1β between the GMSC and PC 
at 24 h (20.07 ± 9.28; 20.51 ± 15.19), 48 h (4.07 ± 2.58; 2.48 ± 1.04), 72 h (3.01 ± 1.76; 3.25 ± 
1.67), 8 days (1.32 ± 1.09; 2.18 ± 1.03), and 21 days (10.60 ± 2.63; 8.70 ± 2.06) (Figure 13C).
Figure 13. Means and standard deviations of IL-10 (A), TNF-α (B), and IL-1β (C) expression in rats in the 
negative control (NC), treated with mesenchymal stem cells (GMSC), and positive control group (PC) at 24, 48, 
and 72 h and at 8 and 21 days after laminectomy or injury (*P < 0.05).
Higher expression of IL-10 was observed in the GMSC at 24 h after surgery and lower 
expression of TNF-α was observed at 8 and 21 days after surgery.
The relative expression of TGF-β was lower in the GMSC than in the PC at 24 h 
(2.53 ± 0.40; 10.31 ± 4.57) and 21 days (4.03 ± 2.34; 7.14 ± 1.58) after injury. There was no 
difference between the GMSC and PC at 48 h (3.90 ± 2.99; 2.89 ± 1.68), 72 h (2.90 ± 0.74; 
3.92 ± 2.26), and 8 days (15.35 ± 12.88; 11.84 ± 7.58) after SCI (Figure 14A).
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There was no difference between the relative expression of BDNF in the GMSC and 
PC at 24 h (1.09 ± 0.43; 0.87 ± 0.32), 48 h (0.71 ± 0.20; 0.60 ± 0.25), 72 h (0.25 ± 0.20; 0.16 
± 0.06), 8 days (0.11 ± 0.04; 0.10 ± 0.03) and 21 days (0.42 ± 0.33; 0.24 ± 0.15) after spinal 
cord injury (Figure 14B).
The relative expression of GDNF was higher in the GMSC than in the PC at 48 h 
(24.45 ± 15.38; 8.22 ± 4.19) and 8 days (1.42 ± 0.62; 0.38 ± 0.12) after SCI. There was no 
difference between the GMSC and PC at 24 h (9.78 ± 2.55; 5.87 ± 3.18), 72 h (2.21 ± 1.48; 
2.48 ± 1.71), and 21 days (0.02 ± 0.01; 0.05 ± 0.02) SCI (Figure 14C).
The relative expression of VEGF was higher in the GMSC than in the PC at 21 days 
after SCI (1.78 ± 0.15; 0.95 ± 0.33). There was no difference in the expression of VEGF 
between the GMSC and PC at 24 h (1.20 ± 0.16; 0.98 ± 0.37), 48 h (0.13 ± 0.4; 0.11 ± 0.07), 
72 h (0.11 ± 0.06; 0.07 ± 0.03), and 8 days (0.22 ± 0.15; 0.19 ± 0.06) (Figure 14D).
Figure 14. Means and standard deviations of TGF-β (A), BDNF (B), GDNF (C), and VEGF (D) expression in 
the negative control group (NC), group treated with mesenchymal stem cells (GMSC), and positive control group 
(PC) at 24, 48, and 72 h and at 8 and 21 days after spinal cord injury (*P < 0.05). In the GMSC, lower expression 
of TGF-β at 24 h and 21 days (A), higher expression of GDNF at 48 h and 21 days (C), and higher expression of 
VEGF 21 days after surgery (D) was observed.
Evaluation of motor function
Animals in the NC presented a score of 21 (maximum score) in all evaluation periods. 
The animals subjected to injury had a score of 0 or 1 in the BBB test at the first evaluation time 
(24 h). There was no significant difference between the scores obtained in the GMSC and PC 
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at 24 h (0.60 ± 0.55; 0.40 ± 0.55) and 48 h (1.50 ± 1.73; 1.10 ± 1.32). The scores were higher 
in the GMSC than in the PC at 72 h (5.00 ± 2.62; 1.4 ± 1.14), 8 days (9.00 ± 2.83; 5.20 ± 2.05), 
and 21 days (9.50 ± 1.92; 6.00 ± 1.41) (Figure 15).
Figure 15. Means and standard deviations of motor function scores in rats in the negative control group (NC), 
group treated with mesenchymal stem cells (GMSC), and positive control group (PC) at 24, 48, and 72 h and at 8 
and 21 days after spinal cord injury. The mean scores for the GMSC were higher than those for the PC at 72 h and 
at 8 and 21 days (*P < 0.05).
DISCUSSION
The absence of significant variation in surface markers and differentiating potential after 
thawing indicate that the MSCs preserved their phenotypic and differentiation characteristics 
after cryopreservation. The reduction in the viability of MSCs after cryopreservation 
did not alter the number of transplanted viable cells; all samples were evaluated before 
transplantation, and the calculation of the number of cells to be transplanted was based on 
the number of viable cells. Higher conversion of MTT observed in the MSCs after 90 days of 
cryopreservation indicated an increase in mitochondrial activity in the cells after thawing. A 
recent study observed an increase in the expression of genes that favor cellular maintenance 
and pluripotency in MSCs of adipose tissue after cryopreservation, even with a significant 
reduction in viable cells (Davies et al., 2014). It is thought that cryopreservation selects for 
more resistant and functional cells.
The activated microglia/macrophages with rounded shape, voluminous cytoplasm, 
and abundant myelin debris are morphological characteristics of anti-inflammatory cells with 
high phagocytic activity (Wirjatijasa et al., 2002; Nakajima et al., 2012; Ishii et al., 2013). In 
the present study, the administration of MSCs favored the activation of microglia/macrophages 
with characteristic anti-inflammatory morphology and reduced the inflammatory infiltrate 
in the white and gray matter 8 days after spinal cord injury, which improved regeneration 
following injury. The reduction in neuron staining by the antibody anti-NeuN 8 days after 
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injury in the MSC group may not be associated with neuronal death, as these cells showed 
characteristics of intact neurons in histopathological evaluation. This may have occurred 
because of metabolic changes that reduced NeuN expression, but did not result in neuron 
death; at 21 days, neuron staining was higher in the same group (MSC). A study performed in 
ischemic brain neurons revealed a decrease in NeuN expression without neuronal death (Ünal-
Çevik et al., 2004).
The reduction in activated astrocytes of the dorsal funiculus at 8 days and in the gray 
matter at 21 days, observed in the MSC group, may be related to the higher expression of 
IL-10 observed in the GMSC group at 24 h after injury, as MSCs can produce this cytokine 
(Nakano et al., 2010; Zhukareva et al., 2010).
Several studies have assessed the effects of IL-10 on spinal cord injury. This cytokine 
displayed anti-inflammatory action, either by direct administration or by the use of other 
treatments that lead to its increase (Bethea et al., 1999; Brewer et al., 1999; Jackson et al., 
2005; Zhou et al., 2009). Some of the results include a reduction in the inflammatory infiltrate, 
activation of cells in the microglia with an anti-inflammatory phenotype (Wirjatijasa et al., 
2002), increase in neuronal survival (Brewer et al., 1999, Jackson et al., 2005; Zhou et al., 
2009), reduction in the activation of astrocytes (Bethea et al., 1999), and improvement of 
motor function (Bethea et al., 1999; Jackson et al., 2005; Zhou et al., 2009). In all of these 
studies, beneficial effects were observed when IL-10 was increased in the first 24 h after spinal 
cord injury (Bethea et al., 1999; Brewer et al., 1999; Jackson et al., 2005; Zhou et al., 2009), as 
observed in the present study. Therefore, IL-10 may be involved in reducing the inflammatory 
infiltrate by activating microglia/macrophage cells with an anti-inflammatory phenotype and 
reducing astrocyte activation.
The reduction in the expression of TNF-α at 8 and 21 days after SCI in the GMSC 
suggests that the inflammatory reaction was less intense in this group, as this cytokine is 
an indicator of the inflammatory process and the activation of microglia/macrophages and 
astrocytes (Bethea et al., 1999; Chen et al., 2015). Another factor demonstrating the reduction 
in the inflammatory response in the GMSC was the lower cell activation in the microglia/
macrophages observed in this study.
The decreased TNF-α expression observed at 21 days in the GMSC is likely related 
to decreased activation of astrocytes; at this evaluation point, the activation of these cells was 
reduced in the gray matter. The reduction of TNF-α may have reduced degeneration of the 
white matter, which was also observed in this group and evaluation time, as TNF-α induces 
apoptosis of neurons and oligodendrocytes and demyelination (Lau and Yu, 2001; Nakamura 
et al., 2003; Yune et al., 2003). The reduced expression of TNF-α in animals subjected to 
spinal cord injury and treated with stem cells has been observed in previous studies (Hawryluk 
et al., 2012; Nakajima et al., 2012). Nevertheless, the mechanisms by which stem cells reduce 
the production of TNF-α had not been determined. In the present study, administration of 
MSCs appeared to reduce the inflammatory infiltrate and activation of astrocytes, and thus the 
production of TNF-α.
The absence of variation in the expression of IL-1β after treatment with MSCs may 
have occurred, because this cytokine is mostly produced by astrocytes that make up the blood 
brain barrier and not by the inflammatory infiltrate, as with TNF-α (Ledeboer et al., 2000; Lau 
and Yu, 2001). Disruption of the blood brain barrier induced by injury likely stimulated IL-1β 
production, and the MSCs were not able of halt this process.
TGF-β is a neurotrophic factor known for its role in the repair of tissue lesions, 
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and its expression increases in the first days after spinal cord injury (Nakamura et al., 2003; 
Hawryluk et al., 2012). The reduced expression of TGF-β observed at 24 h after injury in the 
GMSC suggests that the MSCs reduced the production of this protein. TGF-β opposes the 
action of IL-10, which is unfavorable for regeneration of the spinal cord, because initially, it 
increases the expression of adhesion molecules and activates microglia/macrophage cells with 
a pro-inflammatory phenotype (Wirjatijasa et al., 2002). Thus, the reduction in the expression 
of TGF-β at 24 h after injury in the GMSC may also have contributed to reduction of the 
inflammatory infiltrate and activation of cells with anti-inflammatory characteristics observed 
in this same group at 8 days after injury. The lower expression of TGF-β observed at 21 days 
in the GMSC can be attributed to the reduction in activated astrocytes observed in this group 
and time of evaluation, as astrocytes are the main producers of this neurotrophin (Wirjatijasa 
et al., 2002; Kohta et al., 2009). Furthermore, TGF-β has autocrine functions, inducing those 
of proliferation and activation of additional astrocytes that help form the glial scar, which 
functions as a physical barrier and prevents axon regeneration (Bethea and Dietrich, 2002). A 
previous study showed that blocking TGF-β improved motor function recovery after spinal 
cord injury (Kohta et al., 2009). Similarly, the reduced TGF-β expression observed at 21 days 
in the GMSC may also have decreased formation of the glial scar and stimulated the recovery 
of motor function in the present study.
As observed in previous studies (Hawryluk et al., 2012; Mead et al., 2014), MSCs 
cannot produce or stimulate the synthesis of BDNF. However, some authors reported increased 
expression of BDNF in animals subjected to injury and treated with MSCs (Osaka et al., 
2010; Zhou et al., 2013; Kingham et al., 2014). This divergence in results may be related to 
the different times of MSC administration after injury. MSCs modify their secretion profile 
according to their microenvironment. In addition, there is variability in the production capacity 
of neurotrophins among MSCs from different individuals and tissues (Zhukareva et al., 2010; 
Mead et al., 2014).
The increase in GDNF expression observed at 72 h and 8 days in the GMSC indicates 
that these cells secreted or stimulated medullary parenchyma cells to produce GDNF. In the 
present study, the increased expression of GDNF was associated with a higher number of 
intact neurons, lower degeneration of white matter, and recovery of motor function in the 
GMSC. Other studies showed that GDNF could increase neuronal survival, reducing axonal 
retraction and stimulating axonal sprouting, thus promoting the recovery of motor function 
after SCI (Dolbeare and Houle, 2003; Hawryluk et al., 2012; Lin et al., 2014).
The increased expression of VEGF observed at 21 days after injury in the GMSC 
suggests that these cells produced VEGF or stimulated the medullary parenchyma cells to 
produce VEGF. The increase in VEGF occurred only during the chronic phase of spinal cord 
injury, i.e., in the period during which tissue repair begins. VEGF is known to stimulate 
angiogenesis, an important process that reduces ischemia and provides the blood supply 
needed for axon regeneration and motor function recovery (Figley et al., 2014; Li et al., 2014). 
A previous study found an increase in the concentration of VEGF in the chronic phase of 
animals with SCI treated with MSCs (Li et al., 2014). VEGF has direct neuroprotective and 
neurotrophic actions (Figley et al., 2014; Mead et al., 2014; Shinozaki et al., 2014); therefore, 
the increase in VEGF expression at 21 days after spinal cord injury in the GMSC may have 
contributed to a higher number of intact neurons, lower degeneration of white matter, and 
recovery of motor function.
In this study, the functional recovery observed in GMSC animals was associated with 
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reduction of the inflammatory infiltrate, lower activation of astrocytes, higher activation of 
cells in the microglia/macrophages with morphology typical of anti-inflammatory cells, and 
lower intensity in the degeneration of white matter. Therefore, in this study, cryopreserved 
allogeneic MSCs increased the expression of anti-inflammatory cytokine IL-10 (24 h post-
injury) and the neurotrophic factors GDNF (72 h and 8 days post-injury) and VEGF (21 days 
post-injury) and reduced the expression of the pro-inflammatory cytokine TNF-α (8 days 
post-injury) and neurotrophic factor TGF-β (24 h and 21 days post-injury), stimulating an 
immunomodulatory and neuroprotective effect in rats subjected to spinal cord injury.
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